17.09.2019 • NewsElaine BurridgePfizerValeant

Koreans to Buy Valeant’s Former Vietnam Plant

Koreans to Buy Valeant’s Former Vietnam Plant (c) JW Pharma
Koreans to Buy Valeant’s Former Vietnam Plant (c) JW Pharma

South Korea’s JW Pharmaceutical has picked up a 35,000-square-meter production facility in Vietnam once owned by US pharma Valeant as part of a plan to target emerging markets.  Terms of the deal in which the Seoul-based drugmaker bought Euvipharm were not disclosed.

The facility, believed to be the largest in Vietnam, is approved by the World Health Organization and is capable of producing up to 1.9 billion units a year. According to Korea Biomedical Review, JW wants to use the location in the Hoa District in Long An province as a base to export to other Asian countries and also intends to use it for contract manufacturing.

Valeant, now known as Bausch Health, acquired the premises in 2013 during its expansion drive but later listed it among assets it planned to divest to relieve part of its staggering debt load.

Reports say Vietnam is looking increasingly attractive to Western drugmakers. Pfizer earlier this year announced a deal with Cyprus-based Medochemie to make some of the US company’s drugs in the Southeast Asian country, including some injectables. Medochemie has three manufacturing sites in Vietnam.

In 2018, Hikma acquired Medlac Pharma Italy, a Vietnamese injectables manufacturer established ten years ago as a Vietnamese/Italian joint venture and with it an injectables plant in Hanoi and nearly two dozen drugs.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.